| Literature DB >> 24852165 |
Bo-Qia Xie1, Wei Wang2, Wen-Qian Zhang3, Xin-Hua Guo4, Min-Fu Yang5, Li Wang4, Zuo-Xiang He4, Yue-Qin Tian4.
Abstract
PURPOSE: Childhood post-infectious bronchiolitis obliterans (BO) is an infrequent lung disease leading to narrowing and/or complete obliteration of small airways. Ventilation and perfusion (V/Q) scan can provide both regional and global pulmonary information. However, only few retrospective researches investigating post-infectious BO involved V/Q scan, the clinical value of this method is unknown. This preliminary prospective study was aimed to evaluate the correlation of V/Q scan with disease severity, pulmonary function test results, and prognosis in children with post-infectious BO.Entities:
Mesh:
Year: 2014 PMID: 24852165 PMCID: PMC4031120 DOI: 10.1371/journal.pone.0098381
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Disease severity evaluation method.
| Components of Severity | Score | |||
| 0 | 1 | 2 | 3 | |
|
| None | Mild | Moderate | Severe |
|
| None | Intermittent | Persistent | Severe |
|
| None | With strenuous activity | With mild activity | With rest |
|
| None | Occasionally | Persistent | Severe |
Patient's disease severity was defined as none (summed score = 0), mild (summed score ranged from 1 to 3), moderate (summed score ranged from 4 to 7), and severe (summed score ranged from 8 to 12).
Clinical characteristics and imaging results of patients (n = 25).
| Patient No. | Gender | Age (month) | Age at initial lung insult (month) | Symptoms | Chest X-ray | HRCT | PO2 (%) | PCO2 (%) | Disease severity | Days of hospitalization | VI | PI |
|
| Male | 30 | 29 | Nasal flaring, cyanosis, retractions, crackles | — | Be, consolidation | 43 | 42 | 3 | 67 | 1.94 | 1.32 |
|
| Male | 52 | 11 | — | — | BWT | 69 | 39 | 1 | 31 | 1.50 | 1.03 |
|
| Male | 8 | 5 | Crackles | Consolidation | Be, consolidation | 65 | 40 | 2 | 33 | 1.38 | 0.74 |
|
| Male | 23 | 21 | Crackles | — | BWT | 84 | 42 | 2 | 14 | 0.29 | 1.18 |
|
| Male | 132 | 131 | Nasal flaring, retractions | — | Be | 83 | 34 | 2 | 30 | 1.47 | 0.21 |
|
| Male | 22 | 16 | — | — | 100 | 29 | 1 | 10 | 0.09 | 0.09 | |
|
| Female | 10 | 7 | — | — | 74 | 29 | 1 | 44 | 1.29 | 0.35 | |
|
| Female | 47 | 36 | Fever, crackles | — | Consolidation | 45 | 37 | 2 | 36 | 0.50 | 0.26 |
|
| Female | 88 | 84 | Fever, crackles | Consolidation | Consolidation | 75 | 30 | 2 | 58 | 1.12 | 0.88 |
|
| Male | 120 | 2 | Crackles | — | 57 | 32 | 1 | 26 | 0.44 | 0.85 | |
|
| Male | 18 | 12 | Crackles, retractions | Consolidation | Hyperinflation, consolidation | 64 | 35 | 3 | 54 | 1.59 | 1.68 |
|
| Male | 67 | 24 | Fever, crackles | Atelectasis | Be, consolidation, | 65 | 32 | 2 | 55 | 1.88 | 1.88 |
|
| Male | 12 | 9 | Crackles | — | Consolidation | 74 | 39 | 2 | 37 | 1.06 | 0.38 |
|
| Male | 11 | 9 | Fever, dyspnea, retractions, nasal flaring, crackles | Consolidation | Be, consolidation | 60 | 36 | 3 | 84 | 2.15 | 2.15 |
|
| Male | 11 | 6 | Fever | Consolidation | Consolidation | 66 | 31 | 3 | 47 | 2.12 | 0.88 |
|
| Female | 19 | 1 | Crackles | — | 75 | 32 | 1 | 13 | 0.12 | 0.12 | |
|
| Female | 60 | 1 | Fever | Consolidation | BWT | 62 | 35 | 3 | 59 | 2.18 | 2.18 |
|
| Female | 28 | 9 | Crackles | — | Consolidation | 73 | 36 | 2 | 43 | 1.41 | 1.41 |
|
| Male | 28 | 16 | Crackles | Consolidation | Consolidation | 77 | 36 | 1 | 31 | 1.71 | 1.06 |
|
| Male | 44 | 36 | Fever, cyanosis, retractions | Consolidation | Consolidation | 64 | 44 | 3 | 50 | 1.82 | 0.35 |
|
| Male | 108 | 107 | Nasal flaring, cyanosis, retractions, crackles | Hyperinflation, consolidation | Consolidation | 46 | 47 | 3 | 79 | 2.74 | 1.53 |
|
| Female | 84 | 83 | Fever, crackles | Consolidation | Hyperinflation, consolidation | 66 | 33 | 2 | 44 | 1.24 | 0.82 |
|
| Male | 144 | 142 | Fever | Consolidation | Hyperinflation, consolidation | 96 | 33 | 1 | 19 | 0.24 | 0.18 |
|
| Male | 10 | 8 | Crackles | Consolidation | BWT | 100 | 27 | 1 | 21 | 0.06 | 0.06 |
|
| Male | 32 | 21 | Fever, crackles, retractions | Consolidation | BWT, consolidation | 46 | 61 | 3 | 54 | 1.41 | 1.41 |
All patients had persistent cough and wheezing, so these manifestations were not listed in the symptoms column. All patients showed mosaic pattern and air trapping by HRCT, so these imaging findings were not listed in the HRCT column. BWT = bronchial wall thickening; Be = Bronchiectasis
Figure 1HRCT of patient No.-glass pattern with air trapping and bronchial thickening.
Figure 2Fiberoptic bronchoscopy of the same patient shown in Figure 1.
Complete obstructions were observed in the subsegmental anterior basal bronchus of the left lower lobe (A) and in the subsegmental lateral bronchus of the right middle lobe (B).
Figure 3Three patterns of V/Q scan (A. mismatched ventilation; B. mismatched perfusion; C. matched ventilation-perfusion) in post-infectious BO children (patient No. 4, patient No. 21 and patient No. 12), displayed in 8 views.
POS = posterior, RPO = right posterior oblique, RL = right lateral, RAO = right anterior oblique, ANT = anterior, LAO = left anterior oblique, LL = left lateral, LPO = left posterior oblique.
Spearman's rank correlation test of VI and PI on disease severity, days of hospitalization, and lung function tests parameters.
| Variable | VI | PI | ||
| R | P value | R | P value | |
|
| 0.72 | 0.00 | 0.62 | 0.00 |
|
| 0.80 | 0.00 | 0.73 | 0.00 |
|
| −0.94 | 0.01 | −0.77 | 0.07 |
|
| −0.94 | 0.01 | −0.49 | 0.33 |
|
| −0.77 | 0.07 | −0.37 | 0.47 |
|
| −0.63 | 0.02 | −0.28 | 0.33 |
|
| −0.57 | 0.03 | −0.28 | 0.34 |
|
| −0.62 | 0.02 | −0.49 | 0.08 |
|
| 0.62 | 0.02 | 0.42 | 0.14 |
R = Spearman's rank correlation coefficient
Pulmonary function results in cooperative patients.
| Patient No. | FVC | FEV1
| MMEF | Response to bronchodilator |
|
| 42.1 | 26.8 | 10.3 | Negative |
|
| 78.8 | 84.7 | 70.0 | Negative |
|
| 41.7 | 30.6 | 12.8 | Negative |
|
| 29.0 | 24.6 | 12.9 | Negative |
|
| 79.8 | 72.9 | 57.6 | Negative |
|
| 89.8 | 93.5 | 79.8 | Positive |
|
| 60.2±25.5 | 55.5±31.6 | 40.6±32.1 |
*Values given as percent of predicated values.
Pulmonary function results in infants and young children.
| Patient No. | VT/kg (ml/kg) | TPEF%TE (%) | VPEF%VE (%) | Crs/kg (ml/kPa/kg) | Rrs (kPa*s/L) | Response to bronchodilator |
|
| 8.5 | 10.7 | 12.7 | 4.9 | 6.0 | Negative |
|
| 7.7 | 7.9 | 14.0 | 6.9 | 6.5 | Positive |
|
| 8.4 | 19.8 | 26.2 | 8.1 | 4.0 | Negative |
|
| 10.8 | 16.2 | 20.5 | 11.9 | 3.7 | Negative |
|
| 8.3 | 14.7 | 17.5 | 6.3 | 5.5 | Negative |
|
| 9.5 | 13.2 | 16.6 | 7.6 | 5.4 | Negative |
|
| 8.6 | 10.4 | 11.1 | 9.9 | 5.8 | Negative |
|
| 7.7 | 11.5 | 17.1 | 7.0 | 5.8 | Positive |
|
| 9.3 | 10.3 | 13.9 | 9.2 | 5.2 | Negative |
|
| 8.0 | 17.9 | 21.3 | 10.6 | 3.4 | Negative |
|
| 9.2 | 17.3 | 21.2 | 8.0 | 5.6 | Negative |
|
| 6.1 | 12.2 | 17.3 | 3.6 | 6.2 | Negative |
|
| 7.9 | 21.2 | 25.9 | 9.7 | 2.1 | Positive |
|
| 9.8 | 11.8 | 16.5 | 7.0 | 5.1 | Negative |
|
| 8.6±1.1 | 13.9±4.0 | 18.0±4.6 | 7.9±2.2 | 5.0±1.2 |